Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The picture on IH is a little misleading and makes it look like a very small lab because it has been cropped. The same picture on Ryan's Facebook page is much more impressive and gives a more professional image because it shows more of the lab.
At the current share price Josh should be buying back shares.
I'm going to try some for my cat, and there is a discount code that I found
American Premium Water Corp. (OTC:HIPH) Announces LALPINA HYDRO CBD Beverage Launch
6:00 am ET August 27, 2018 (Globe Newswire)
American Premium Water Corporation (OTC:HIPH) (the "Company") announces that it has launched its LALPINA Hydro CBD product for sale today on its website (www.lalpinawater.com). The Company encourages the investor community to try the product out themselves; for the next week, the Company is offering a special 15% discount for investors. Use the code CBD15 at checkout.
The Difference Between Copyright and Trademark. While both offer intellectual property protection, they protect different types of assets. Copyright is geared toward literary and artistic works, such as books and videos. A trademark protects items that help define a company brand, such as its logo.
It looks like they are trying to get trademark status for a specific reason.
The latest updates from Josh have been very promising, but have failed to give any information on the status of the AMS deal. If someone has contact with Josh it would be nice to to get an update on the AMS transaction.
Remember this was the driver when the stock went to .0057 and I believe it is still main impetus for anyone investing in BLDV.
When Cleve Tsai was running the company he had contacted Scott and had an arrangement to work together. I wonder if any arrangement is still in place.
I'm surprised more hasn't been posted about the sale going through. This is clearly a positive development for BLDV.
All they need to do now is get atmospheric water generators and MTG generators from a company like Water Technologies International Inc (WTII) and the whole operation can be self sufficient.
Hopefully the licence goes through quickly.
BRISTOL, Va. — Twin City firm Par Ventures LLC has finalized its acquisition of the Bristol Mall for $2.6 million.
The transaction was completed and paperwork filed with the Circuit Court Clerk’s office last Friday. Par Ventures first announced its intent to purchase the mall last month, at the same time it announced plans to lease space to a startup pharmaceutical company planning to produce and market cannabidiol oil at the facility.
Maybe BLDV will absorb AMS and then rent out the AMS building (50,000 sq ft) to Quality Green.
I had called Scott when Cleve Tsai was running BLDV and gave him Cleve's contact information; later WTII was listed as a partner with BLDV. I was wondering if WTII is still partnering with BLDV since you appear to have some contact with Joshua.
Recent article should have a positive impact on all MJ stocks:
SPONSORED ARTICLE
Billionaire Investors Backing A Marijuana Boom In 2017
By James Burgess - Jul 16, 2017, 6:30 PM CDT
The biggest multi-decade opportunity for investors right now is the Canadian government’s legislation to legalize recreational marijuana by this time next year—and the first companies to win government approval will the high-risers.
In a sector that’s already seen stocks bust the borders with 1000% spikes, there is one company that currently has 2 of the only 50 licenses to cultivate in Canada, positioning itself to burst out of the gates as new legislation creates a multi-billion-dollar industry over night.
With one of the largest land packages to build cultivation facilities and 2 current licensed facilities located in two provinces in Canada, small-cap Invictus MD (TSX:IMH.V; OTC:IVITF) is set to rise.
It’s already the first licensed medical marijuana company to pay a dividend to shareholders, and with its strains reaching into everything from pain management, cancer, epilepsy, anxiety and – most lucratively of all—recreation, the sky is the limit here.
We’re now just shy of a year away from the start date of legal recreational use, and there are already predictions of a looming supply shortage.
Financial Post reports... there will soon be 3.8 million recreational users... But the market is only currently equipped to handle 150,000 medical marijuana patients.
The industry is scrambling to add growing capacity once the legal barriers are tossed aside.
Deloitte estimates this industry could be worth a whopping $22.6 billion annually. That’s more than the combined sales of beer, wine and spirits.
Right out of the gate, Invictus MD, owner of two of just 50 licenses, has demonstrated that it will lead the way. The company holds $30 million in cash and is already generating dividends—a feat unheard of in the pot industry.
That’s why it’s called ‘Canada’s Cannabis Company’—it’s already cemented market share for medical marijuana use, and now it’s one of the first in and ready to fill the supply gap for a massive recreational push to supply 3.65 million new users.
When you suddenly legalize a product that’s already got a massive market under the table, you mint billionaires overnight. Just like it did at five o’clock on December 5, 1933—the moment Prohibition ended, and a billion-dollar industry (even then) was reborn.
It’s already happening: The shares of the medical marijuana producers more than tripled last year, just at the prospects.
• AXIM Biotechnologies (NASDAQOTH:AXIM): exploded 1,720 percent
• Corbus Pharmaceuticals (NASDAQ:CRBP) was up 431 percent
• Aphria (NASDAQOTH:APHQF) grew 381 percent
• Aurora Cannabis (NASDAQOTH:ACBFF) was up 299 percent
• Canopy Growth Corp. (NASDAQOTH:TWMJF) up 259 percent
• Medical Marijuana (NASDAQOTH:MJNA) up 254 percent
• GW Pharmaceuticals (NASDAQ:GWPH) was up 64 percent
The smart money is investing too. Tribeca Investment Partners, a boutique fund manager, used bets on marijuana companies to help generate a 145 percent return over the year, according to Fortune magazine and Bloomberg. Nearly US$20 million of its investment gains in 2016 came from marijuana stocks, including Aurora Cannabis and Canopy Growth.
Then, in early April, Canada launched its first marijuana exchange-traded fund (ETF), giving investors diverse exposure to this tantalizing sector. The Horizons Medical Marijuana Life Sciences ETF (TSX:HMMJ) launched on the 4th of April on the Toronto Stock Exchange with 11 Canadian-listed stocks and four U.S.-listed stocks.
On 23 June, Invictus was included in the ETF.
The frenzy surrounding Canada’s marijuana market is palpable, and will be even more frenzied on 1 July 2018.
Thanks for the info.
What amendment
Does it concern you that they have authorized 200,000,000,000 shares of Class C stock that can be converted to common? I have not sold any of my position, but it makes me a bit nervous especially since there has been no announcement for the purpose that these shares will be used for.
No. If you use the 800 million number as the float that would be about 1/8 of the float.
I think everyone that owns stock in this company is entitled to know what they plan to do with the class C stock; and owning 102,832,725 shares doe not entitle me to insider information.
The application said 200,000 million That would be 200 billion class C stock
This was part of the filing that cancelled the reverse split. As a stockholder holding more than 100 million shares I'm certainly interested in seeing the price go up, but what I'd like to know is what they are planning to do with those 200 billion hares of C class stock that can be converted to common on a 1 to 10 conversion rate. If they are going to use these shares to fund the operation will the holders flood the market later when they are converted?
One thing that is disconcerting is the class C stock in the filing with the SOS. 200,000 million shares (200 billion) that can be converted to common stock on a 1 for 10 basis.
AGX sitting on tons of cash, dividend distribution is imminent
Because our friend JQM doesn't keep us (the investors) informed, our conclusions are nothing more than guesses.
That doesn't mean I'm not hopeful of a successful outcome for BLVD in the end.
Having built several bio-diesel plants along the gulf ranging in size from 40MM gals/yr to 150MM gals/year I can tell you that the cost of a plant ranges from .60/gal to .80/gal depending on weather it is a batch process or continuous process as well as how much automation is engineered into it. Therefore a 100MM gal/yr facility would cost approximately $70MM; plus raw material and operational costs. As has been suggested by earlier posts hopefully JQM has put the additional 400MM shares in the hands of some investors to raise capitol, otherwise its not very apparent where he will get the funds necessary since he's not very forthcoming with information about the company's plans.
As for feed stock, algae seems the most promising from my perspective. There are several companies that have engineered stains specifically for their oil content. One company has developed 26 different types that can grow in various environments and has a potential yield of 20,000 gals/yr/acre. If JQM is going to develop a vertically integrated bio-fuel company that would be his best option.
All of this can be done now, but if he doesn't have the funds then is just a pipe dream and we're wasting our money (investment).
I'm hoping for the best and trying to stay optimistic.
According to the article the US Military will also support biofuels by purchasing at least 50% of its requirement for jets. If JQM has any real business plan BLVD will benefit otherwise the scam will eventually come to an end as some have predicted.
http://www.usatoday.com/money/industries/energy/environment/2009-01-27-alternative-jet-fuels_N.htm
What happened to the volume?